logo
Short Report: Clear Secure bears cover as strong guidance lifts shares

Short Report: Clear Secure bears cover as strong guidance lifts shares

Business Insider8 hours ago
Welcome to this week's installment of 'The Short Interest Report' – The Fly's weekly recap of short interest trends among some of the most widely followed high-short-float stocks. Using the data from our partner Ortex.com, which utilizes the latest information from stock lenders to estimate short interest changes for thousands of publicly traded companies, this report will screen for some of biggest changes in short interest as a percentage of free float and days-to-cover ratios while also considering the short interest data on some of the more volatile and heavier-traded names of the week. Based on the availability of data from Ortex, the report tracks the trading period that covers prior Friday through Thursday of this week, excluding holidays. As a basis of comparison for stocks discussed below, the S&P 500 index was flat, the Nasdaq Composite was up 0.6%, the Russell 2000 index up 0.1%, the Russell 2000 Growth ETF (IWO) was up 0.3%, and the Russell 2000 Value ETF (IWN) was up 0.2% in the five-day trading session range through August 7.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SHORT INTEREST GAINERS
Ortex-reported short interest in Lucid Group (LCID) had troughed at a two-month low of about 29% heading into the company's August 5th earnings, though with investors disappointed Lucid's wider than expected loss, bears are again boosting their exposure. Shorts as a percentage of free float accelerated from 29.5% to 31.8% and days-to-cover on the higher-end EV automaker rose from 4.3 to 5.3, with little relative trading volume increases accompanying its quarterly results. Just three weeks ago, the stock experienced an intra-day spike of nearly 50% when the company announced an autonomous robotaxi partnership with Uber and Nuro, with the aim to deploy 20,000 or more Lucid vehicles equipped with the Nuro Driver over six years. Since then however, all of those gains have been erased. This week, Lucid shares fell 13% in the five-day period covered, and the stock is now down 29.5% year-to-date.
Ortex-reported short interest in Enovix (ENVX) had fallen to a multi-year low around 19% in late July, though with the stock also reversing much of its recent rally following a modest beat and in-line Q3 outlook after its July 31st earnings, bears are also turning less leary. Shorts as a percentage of free float on the name rose from 19.2% to 22.1%, though days-to-cover is down from 8.4 to 7.8 given the increase in trading volume. Enovix shares were down 18% in the five-day period covered, though even after Friday's 2% slide, the stock is down just 1% year-to-date.
Ortex-reported short interest in Frontier Group (ULCC) is flying higher as the stock price has resumed its descend following a wider than expected Q2 loss and disappointing guidance for Q3. Shorts as a percentage of free float on Frontier rose from 27.6% to 31.2%, matching the highs above 31% set in mid- and late-June, while days-to-cover on the budget airline jumped from 5.4 to 6.8 despite large trading volume the day of and the day after earnings on August 5th and 6th. The turbulent stock, meanwhile, was down 24% in the five-day period through Thursday, having fully erased its June 23 to July 29 trough to peak 53% rally and closing in on this year's low.
SHORT INTEREST DECLINERS
Ortex-reported short interest in Clear Secure (YOU) is caving after the company reported Q2 results that saw a beat on revenue and also better than expected outlook for sales in Q3. Shorts as a percentage of free float – already down from outsized high-30% levels seen in mid-June – had settled into mid-20% levels but fell further from 24.3% to 21.7% – a three-month low – this week on post-earnings short-covering. Days to cover also retreated from 5.4 to 5.1 as volumes ticked higher. The stock was up as much as 14% intraday following Clear Secure's results and gained 8.6% overall during the five-day period covered through Thursday. Year-to-date, shares are now up 20%.
Ortex-reported short interest in Birkenstock (BIRK) is down sharply heading into the company's Q3 results this coming Thursday. Coming out of its earnings in Q2 in May, the stock jumped a solid 6%. Shorts as a percentage of free float had reached 2025 highs around 25% earlier in the week but collapsed to 16% just as shares slipped to three-week lows. Low trading volume this week lifted the days-to-cover on the name however from 3.4 to 4.2. Over the five-day period covered, Birkenstock shares traded down by 3.2% and have now shed 15% year-to-date.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Stocks Keeps Rising—Despite Trump's Tariff Chaos
Why Stocks Keeps Rising—Despite Trump's Tariff Chaos

Time​ Magazine

timean hour ago

  • Time​ Magazine

Why Stocks Keeps Rising—Despite Trump's Tariff Chaos

As America hikes tariffs sharply, the jobs market slips, and President Donald Trump turns his ire from Harvard to the Bureau of Labor Statistics the stock market refuses to collapse. Despite these economic speed bumps, the S&P 500 Index is up nearly 8% so far this year. How long this rise can continue depends on whether the fundamental strength of the U.S. economy can withstand the wrenching transformation to the global trading system that President Trump has forced. Economics textbooks insist that stock prices reflect the future stream of a company's profits on any given day. For all the brainpower devoted to these forecasts, however, they are essentially rough estimates of what may happen over the next twelve months and wild guesses about anything after that. Over the past several weeks, more companies than usual reported second-quarter results that beat market expectations, and analysts have even slightly raised their estimates for the next three months. Market valuations are higher than historical averages (about 22 times forward earnings) But the bulls argue that this includes those transformative tech firms that will reap handsome rewards from the artificial intelligence revolution. Read More: The Chaotic, Fantastical World of Donald Trump's Tariffs That's all pretty reasonable for an economy that has grown on average 2.8% for the last five years, recovering nicely from COVID-19 lockdowns, powering through the sharpest interest rate increases in 40 years, and still going strong as the president fundamentally redesigns the global trading order. Generous checks and rock-bottom interest rates following the pandemic may explain at least some of this remarkable performance. Still, stocks are all about future expectations, and none of this history reveals much about the impact of the Trump Administration's dramatic policy departures. The 'One Big Beautiful Bill' locked in lower corporate tax rates and delivered a massive boost to defense spending, adding some $3.4 trillion to the deficit over the next decade, according to the Congressional Budget Office. The administration promises, however, that together with a wave of deregulation, growth rates will be more than 1% higher over the next four years. That would be quite something, but most independent economists expect more headwinds from tariffs than tailwinds from tax cuts and deregulation. The International Monetary Fund recently raised global growth forecasts to 3.1% this year—but doesn't expect more than 2% in the U.S. in 2025 or 2026. The problem is that tariffs represent a large stealth tax increase as average rates rise from 2.5% to nearly 20%, depending on what goods are ultimately covered. Not all prices will rise by this much as imports represent just over 10% of the economy, and many companies will absorb some of the higher costs. Still, the $300 billion in tariff revenues that Treasury Secretary Scott Bessent expects this year will be paid by Americans. Worse than this one-off blow, however, is the lingering uncertainty for investors and corporate strategists. Even as Trump's tariffs went into effect on Aug. 7, crucial details of the deals he has announced remain unknown. Meanwhile, Trump has promised more tariffs on pharmaceuticals and semiconductors. And even if pending court cases force him to backtrack on some tariffs, his 'Truth Social' threats of tariffs to pressure Brazilian prosecutors or block India's purchases of Russian oil will keep everyone on their backfoot. Read More: Trump's Decision to Fire BLS Commissioner Echoes Putin's Strategies There's also a big question around Chinese imports, many of which could see tariffs snap back to 145% if the current truce is not extended beyond Aug. 12. Negotiators signaled they might extend the deadline, working towards an agreement that Trump and China's president Xi Jinping could endorse at a fall summit. Then, the White House walked back this suggestion. Indeed, it doesn't take much more than a weather balloon to derail this fragile relationship. Markets delivered a bone-chilling response to Trump's initial 'Liberation Day' tariff announcements in early April with a simultaneous sell-off of U.S. stocks, treasury bonds, and the dollar. If that news came as a jolt, today's rocketing stock prices suggest investors believe the economy can handle higher costs and persistent uncertainty. Or they believe the Fed will be cutting rates soon. But the real test will come in the fall when goods with their new post-tariff price tags start arriving in stores. Will they bring another burst of inflation that the Fed has to fight with delayed rate cuts? Could they damage the holiday spirits of American shoppers and raise the risks of recession? Still worse, might we see both? If a U.S. bombing of Iranian nuclear facilities, escalating fighting in Ukraine, and the president's persistent attacks on the Fed aren't enough to derail this market, it could be a burst of 1970s-style 'stagflation' that does the trick.

Second Quarter Earnings Season: Waiting For NVIDIA
Second Quarter Earnings Season: Waiting For NVIDIA

Forbes

timean hour ago

  • Forbes

Second Quarter Earnings Season: Waiting For NVIDIA

Following the second busiest week, the second-quarter earnings season begins to slow down this week, with just 6 S&P 500 companies scheduled to report. Notable companies scheduled to release earnings include: Deere (DE) and Applied Materials (AMAT). Earnings Season At A Glance According to FactSet, 81% of S&P 500 companies have reported earnings above consensus estimates, with 90% of companies having already reported results. Earnings Estimates Summary Companies reporting and combining actual results with consensus estimates for companies yet to report, the S&P 500's blended earnings growth rate for the quarter is at 11.8% year-over-year, well above the 4.9% expectations at the end of the quarter. Notably, the expected earnings growth rate for calendar year 2025 is 10.3%, and for 2026, the expectation is 13.3%. Market Performance Following the better earnings results, the S&P 500 came within a hair of an all-time high last week, while the Magnificent 7 reached a new peak. The Magnificent 7, comprising Microsoft (MSFT), Meta Platforms (META), (AMZN), Apple (AAPL), NVIDIA (NVDA), Alphabet (GOOGL), and Tesla (TSLA), outperformed primarily due to Apple and Tesla. Magnificent 7 Because these companies are critical drivers of earnings growth and a significant percentage of the S&P 500's market capitalization, the Magnificent 7 were the group to watch this earnings season, and they did not disappoint aside from Tesla (TSLA). Furthermore, the artificial intelligence (AI) related companies reinforced the positive narrative surrounding the technology. With earnings season nearing completion, all eyes now shift to NVIDIA (NVDA), which is scheduled to report on August 27. Earnings Insights By Sector Positive earnings surprises from the healthcare and communication services sectors were the most significant contributors to the improved earnings picture last week. Better-than-expected earnings from Pfizer (PFE), Eli Lilly (LLY), Amgen (AMGN), and Warner Bros. Discovery (WBD) were the most essential contributors, according to FactSet. Revenue Results By Sector Following better-than-expected data last week, sales growth of 6.3% is ahead of the 4.2% year-over-year expectation at the end of the quarter. Better sales results in the financials and healthcare sectors were the most significant drivers of the improvement in expected revenue growth last week, according to FactSet. What To Watch Next Week Earnings season slows to a crawl beginning this week. While the individual reports are crucial for that stock, none are going to change the overall color of the season at this point. Friday's retail sales numbers will be an essential check on the US consumer. The soft monthly jobs report with massive downward revisions to start the month was worrisome for the health of the economy. Since the consumer drives the US economy, retail sales will be closely watched to see if the labor market is spilling over to spending. Consumer inflation (CPI) on Tuesday will be notable as the odds of a September short-term interest rate cut from the Federal Reserve (Fed) have risen to 90% following the weaker-than-expected jobs report. Year-over-year CPI is expected to increase to 2.8% from 2.7%, but the data will be watched for signs that the Fed needs to delay any cuts to fight inflation. There is still one more monthly jobs report before the Fed's September meeting, and barring an abnormally large inflation surge, the labor market will be the primary driver behind any rate cuts or lack thereof. In addition, markets have now fully priced in at least two rate cuts of 25 basis points (0.25%) in 2025. Newsflow about the administration's trade negotiations and new tariff announcements will remain a market mover. Berkshire Hathaway (BRK/A, BRK/B) releases its 13F filing after the close on Thursday. Warren Buffett continues to be a net seller of stocks, but this report provides the details. An analysis of Berkshire's quarterly earnings is here. The increase in worries about the economy in the wake of a shockingly poor jobs report eased this week, with the betting odds of recession falling to the lows of the year. The falling odds of recession and another week of better-than-expected earnings sent stocks to near record highs.

2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade

Yahoo

time3 hours ago

  • Yahoo

2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade

Key Points Shares of Brookfield Infrastructure and Novo Nordisk offer an average yield that is more than triple the market average. Novo Nordisk lowered its forward outlook in response to a problem that has most likely been resolved already. Brookfield Infrastructure's pipelines and data centers aren't particularly thrilling, but they do generate predictable cash flows. 10 stocks we like better than Novo Nordisk › Despite a recent dip in response to unfavorable economic data, the stock market's bull run seems unstoppable. From April 4 through Aug. 8, the S&P 500 index shot up a whopping 25.9%. For dividend-seeking investors, a buoyant stock market can be a little annoying. Stock prices rising faster than profits means most dividend payers offer unattractive yields. The average yield from dividend payers in the benchmark S&P 500 index is an unattractive 1.2% at recent prices. Most dividend yields aren't particularly desirable right now, but there are still some underappreciated gems hiding in plain sight. Novo Nordisk (NYSE: NVO) and Brookfield Infrastructure (NYSE: BIP)(NYSE: BIPC) offer an average yield of 3.9% at recent prices. Plus, they could raise their payouts at a mid-single-digit percentage, or better, every year from now until you want to retire. You don't have to be wealthy to put your money to work with these stocks. At recent prices, $100 is enough to buy a share of both. Here's why that looks like a great idea for folks who would like to grow their passive income streams. Novo Nordisk From the end of 2023 through Aug. 7, shares of Novo Nordisk lost more than half their value. Earnings reported by the Denmark-headquartered company that markets Ozempic and Wegovy have performed much better than the stock. If we ignore currency exchange rates, U.S. investors who buy the stock at recent prices would receive a 3.44% yield if Novo Nordisk holds the payout flat. Holding dividend payments steady isn't in this company's nature. From 2020 through 2024, it raised annualized dividend payments by 120% in its native currency. Shares of this drugmaker have been under intense pressure since management lowered its sales outlook for 2025. On Aug. 6, the company told investors to expect revenue to rise between 8% and 14% this year. That's much slower than the 13% to 21% range management provided in May. On the bottom line, management lowered its operating earnings growth outlook to a range of between 10% and 16% this year. This is a slower rate of growth than we had been expecting, but it's still pretty good for an established pharmaceutical business. Shares of Novo Nordisk have been beaten down to just 14.1 times trailing earnings. This valuation implies growth at a low single-digit percentage over the long run. I'd argue that profit growth of around 10% annually seems far more likely. During its initial launch, Novo Nordisk failed to produce enough Wegovy to meet demand, which allowed independent compounding pharmacies to fill in the gap. The Food and Drug Administration declared an end to the Wegovy shortage in February. Compounding pharmacies that have been fighting the decision in U.S. courts without success are a headwind that seems likely to subside. Brookfield Infrastructure Even if you haven't heard of Brookfield Infrastructure, there's a good chance your employer relies on at least one of its assets. This subsidiary of Brookfield Asset Management owns and operates critical infrastructure networks that facilitate the flow of freight, passengers, data, water, and energy. Shares of Brookfield Infrastructure have fallen by about 15% over the past three years, but its dividend payout has risen by 18.5% over the same time frame. At recent prices, the stock offers an unusually large 4.3% dividend yield. Investing in pipelines, fiber optic cables, railways, data centers, toll roads, and telecom towers receives significantly less attention than big tech's investments in artificial intelligence (AI). I'd argue that this is one of the safest AI stocks you can buy now. Nobody knows which large language models will become the most popular over the long run, but we can be sure they will require heaps of energy and data transmission. Brookfield Infrastructure's portfolio includes assets that provide both. During the second quarter, Brookfield Infrastructure reported funds from operations (FFO), a proxy for earnings used to evaluate asset-heavy businesses, that rose 5% year over year to $0.81 per share. This is heaps more than it needs to meet a quarterly dividend payout currently set at $0.43 per share and raise it much further. Adding some shares to a diversified portfolio looks like a nearly surefire way to generate heaps of dividend income over the long run. Do the experts think Novo Nordisk is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Novo Nordisk make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,060% vs. just 182% for the S&P — that is beating the market by 877.64%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Cory Renauer has no position in any of the stocks mentioned. The Motley Fool recommends Brookfield Infrastructure Partners and Novo Nordisk. The Motley Fool has a disclosure policy. 2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store